Auxilium On a Roll ...
Health Care: Drugs
Biocryst Pharmaceuticals (BCRX: NASDAQ)
$3.11 0.19 | 6.51%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -56.95M | -33.85M | -13.45M | -24.73M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 24.40M | 3.49M | -21.74M | 27.15M |
| (Increase) Decrease in Inventories | 635.00K | 5.38M | -6.28M | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -10.73M | -9.43M | 20.20M | -8.96M |
| (Decrease) Increase In Other Current Liabilities | 1.31M | -219.68K | 376.97K | 0.00 |
| (Increase) Decrease In Other Working Capital | -1.55M | -2.55M | -2.54M | -21.63M |
| Other Non-Cash Items | 8.77M | 6.30M | 5.52M | 5.86M |
| Net Cash From Continuing Operations | -32.25M | -28.55M | -16.22M | -20.87M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -32.25M | -28.55M | -16.22M | -20.87M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 137.07M |
| Purchases of Property, Plant & Equipment | -55.00K | -324.76K | -603.69K | -1.21M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -124.46M |
| Other Cash from Investing Activities | 0.00 | 0.00 | -625.00K | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 11.32M | 221.07K | -12.89M | 11.39M |
| Issuance of Debt | 25.69M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.60M | 835.60K | 48.05M | 666.64K |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | -61.00K | -5.01K | -155.50K | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -3.48M | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 23.76M | 830.59K | 47.90M | 666.64K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 2.82M | -27.50M | 18.78M | -8.81M |
Portfolios with BCRX
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- Usertech
- Userrio grande
- UserDebbie0913 Portfolio 1
- UserPART 7 JPMorgan 28th Annual...
- UserSolana Partners
- UserLatest 2009
- ContributorFast Money's 3 Buys & 4...
- User10 shots
- ContributorCramer's Healthcare Stock Buys
Latest BCRX Headlines from TheStreet
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- Biocryst's Gout Drug Fails to Impress 10.05.11 | 11:10 am
- Dendreon's Blowup Spreads Across Biotech 08.04.11 | 10:08 am
- Biotech Stock Mailbag: Vivus 09.24.10 | 07:09 am
- BioCryst Tripped Up by Downgrade 09.23.10 | 04:09 pm
- Savient: Drug Approval or Another Delay? 09.10.10 | 08:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- BioCryst Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 04.28.10 | 06:04 pm
Press Releases for BCRX
- BioCryst To Present At Two Upcoming Investor Conferences - Business Wire 05.22.12 | 06:05 am
- BioCryst Provides Corporate Update And Reports First Quarter 2012 Financial Results - Business Wire 05.07.12 | 06:05 am
- BioCryst To Report First Quarter 2012 Financial Results On May 7, 2012 - Business Wire 04.25.12 | 06:04 am
- BioCryst To Present At Two Upcoming Investor Conferences - Business Wire 02.23.12 | 06:02 am
- BioCryst Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.16.12 | 06:02 am
- BioCryst Announces Promising Results From Preclinical Studies Of BCX5191 For Hepatitis C - Business Wire 02.15.12 | 06:02 am
- BioCryst To Announce Fourth Quarter And Full Year 2011 Financial Results On February 16, 2012 - Business Wire 02.06.12 | 06:02 am
- Nancy Hutson Appointed To BioCryst’s Board Of Directors - Business Wire 01.19.12 | 06:01 am
- BioCryst Announces Positive Results From Its Ongoing BCX4208 Phase 2B Study In Patients With Gout - Business Wire 01.08.12 | 05:01 pm
- BioCryst Pharmaceuticals Presents New BCX4208 Gout Data At The 2011 ACR/ARHP Annual Scientific Meeting - Business Wire 11.08.11 | 06:11 am
Partner Headlines for BCRX
- Today's Market News To Trade On: 5 Stocks Making News - Seeking Alpha 03.23.12 | 08:03 am
- UPDATE: Bird Flu Found in the Netherlands - Benzinga 03.19.12 | 01:03 pm
- Noteworthy Institutional 5% Ownership Filings Last Week - Seeking Alpha 03.19.12 | 09:03 am
- Oink Oink: Profit From The Return Of Swine Flu - Benzinga 01.12.12 | 01:01 pm
- Biotechs And Their Trials By Fire - Seeking Alpha 11.07.11 | 09:11 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.04.11 | 09:11 am
- BioCryst Pharmaceuticals To Present New Peramivir Data at the 51st Annual ICAAC Meeting - Benzinga 09.17.11 | 06:09 pm
- A Bullish Speculative Options Bet and a Bearish One - Seeking Alpha 06.30.11 | 09:06 am
- 7 Speculative Healthcare Stocks to Rejuvenate Your Portfolio - Seeking Alpha 05.31.11 | 08:05 am
- UPDATE 1-BioCryst says influenza drug lowers virus concentration - Reuters 01.13.11 | 08:01 am
